Showing results (131-140 of 431) with videos related to
Sort By:
Pageof 44
Japanese Journal of Clinical Oncology|June 1, 2007
Serum total bilirubin as a predictive factor for severe neutropenia in lung cancer patients treated with cisplatin and irinotecanYutaka Fujiwara, Ikuo Sekine, Yuichiro Ohe, et al.Cancer Chemotherapy and Pharmacology|February 2, 2018
Long-term results of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancerTetsuhiko Taira, Kiyotaka Yoh, Seisuke Nagase, et al.Thoracic Cancer|October 27, 2020
Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non-small cell lung cancer treated with anti-PD-1 antibodyShuji Murakami, Ryota Shibaki, Yuji Matsumoto, et al.Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohortIsamu Okamoto, Satoshi Morita, Naoki Tashiro, et al.Thoracic Cancer|January 20, 2021
HSP90 inhibition overcomes EGFR amplification-induced resistance to third-generation EGFR-TKIsSho Watanabe, Yasushi Goto, Hiroyuki Yasuda, et al.Journal of Cancer Research and Clinical Oncology|July 28, 2022
Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patientsRyoko Inaba Higashiyama, Hidehito Horinouchi, Aya Kuchiba, et al.Cancer Science|September 11, 2019
Individual optimal dose of amrubicin to prevent severe neutropenia in Japanese patients with lung cancerYoshinori Makino, Reiko Makihara-Ando, Takanori Ogawa, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 3, 2011
Risk factors for treatment-related death associated with chemotherapy and thoracic radiotherapy for lung cancerYuko Minami-Shimmyo, Yuichiro Ohe, Seiichiro Yamamoto, et al.Anticancer Research|January 30, 2026
Clinical Activity of MET-TKIs in METex14 Skipping NSCLC With Poor Performance StatusYoh Yamaguchi, Tatsuya Yoshida, Ryoko Inaba Higashiyama, et al.Japanese Journal of Clinical Oncology|September 28, 2010
Lung cancer working group reportNagahiro Saijo, Masahiro Fukuoka, Sumitra Thongprasert, et al.Pageof 44